Intraoperative Evaluation of Axillary Lymphatics with Indocyanine Green and Asimov Imaging Platform for Breast Cancer Patients Undergoing Axillary Surgery
This phase I trial tests whether indocyanine green and Asimov imaging platform works to perform axillary reverse mapping in patients with breast cancer undergoing axillary surgery. Axillary reverse mapping is a way for the surgeon to see the lymphatic channels that travel from the arm. Saving those lymphatics may decrease risk of developing lymphedema – or arm swelling – after surgery. Most surgeons use blue dye to guide axillary reverse mapping. Although the use of fluorescence imaging for axillary reverse mapping has been described in research studies, there are limitations with the currently available fluorescence-imaging platforms that make them difficult to use for this purpose. This research is being done to test the feasibility of a new technology platform (Asimov Imaging) that may address some of the limitations of prior techniques and improve the ability to perform axillary reverse mapping.